Europe Bioreactors Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Europe Bioreactors Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Europe Bioreactors Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Europe Bioreactors Market Regional Analysis

6.2 Europe Bioreactors Market Revenue 2020-2030 (US$ Million)

6.3 Europe Bioreactors Market Forecast Analysis

7. Europe Bioreactors Market Analysis – by Scale

7.1 Lab-Scale Production

7.1.1 Overview
7.1.2 Lab-Scale Production: Europe Bioreactors Market – Revenue and Forecast, 2020-2030 (US$ Million)

7.2 Pilot-Scale Production

7.2.1 Overview
7.2.2 Pilot-Scale Production: Europe Bioreactors Market – Revenue and Forecast, 2020-2030 (US$ Million)

7.3 Full-Scale Production

7.3.1 Overview
7.3.2 Full-Scale Production: Europe Bioreactors Market – Revenue and Forecast, 2020-2030 (US$ Million)

8. Europe Bioreactors Market Analysis – by Application

8.1 Microbial Application

8.1.1 Overview
8.1.2 Microbial Application: Europe Bioreactors Market – Revenue and Forecast, 2020-2030 (US$ Million)

8.2 Cell Culture Application

8.2.1 Overview
8.2.2 Cell Culture Application: Europe Bioreactors Market – Revenue and Forecast, 2020-2030 (US$ Million)

9. Europe Bioreactors Market Analysis – by Technology

9.1 Fed-Batch Bioreactors

9.1.1 Overview
9.1.2 Fed-Batch Bioreactors: Europe Bioreactors Market – Revenue and Forecast, 2020-2030 (US$ Million)

9.2 Perfusion Bioreactors

9.2.1 Overview
9.2.2 Perfusion Bioreactors: Europe Bioreactors Market – Revenue and Forecast, 2020-2030 (US$ Million)

10. Europe Bioreactors Market Analysis – by End User

10.1 Biopharma Manufacturers

10.1.1 Overview
10.1.2 Biopharma Manufacturers: Europe Bioreactors Market – Revenue and Forecast, 2020-2030 (US$ Million)

10.2 Research and Development Organizations

10.2.1 Overview
10.2.2 Research and Development Organizations: Europe Bioreactors Market – Revenue and Forecast, 2020-2030 (US$ Million)

10.3 Contract Manufacturing Organization

10.3.1 Overview
10.3.2 Contract Manufacturing Organization : Europe Bioreactors Market – Revenue and Forecast, 2020-2030 (US$ Million)

11. Europe Bioreactors Market – Europe Analysis

11.1 Overview

11.2 Europe

11.2.1 Europe Bioreactors Market Breakdown, by Key Country, 2023 and 2030 (%)
11.2.1.1 Europe Bioreactors Market – Revenue and Forecast Analysis – by Country
11.2.1.1 UK: Europe Bioreactors Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.1.1 UK: Europe Bioreactors Market Breakdown, by Scale
11.2.1.1.2 UK: Europe Bioreactors Market Breakdown, by Application
11.2.1.1.3 UK: Europe Bioreactors Market Breakdown, by Technology
11.2.1.1.4 UK: Europe Bioreactors Market Breakdown, by End User

11.2.1.2 Germany: Europe Bioreactors Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.2.1 Germany: Europe Bioreactors Market Breakdown, by Scale
11.2.1.2.2 Germany: Europe Bioreactors Market Breakdown, by Application
11.2.1.2.3 Germany: Europe Bioreactors Market Breakdown, by Technology
11.2.1.2.4 Germany: Europe Bioreactors Market Breakdown, by End User

11.2.1.3 France: Europe Bioreactors Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.3.1 France: Europe Bioreactors Market Breakdown, by Scale
11.2.1.3.2 France: Europe Bioreactors Market Breakdown, by Application
11.2.1.3.3 France: Europe Bioreactors Market Breakdown, by Technology
11.2.1.3.4 France: Europe Bioreactors Market Breakdown, by End User

11.2.1.4 Russia: Europe Bioreactors Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.4.1 Russia: Europe Bioreactors Market Breakdown, by Scale
11.2.1.4.2 Russia: Europe Bioreactors Market Breakdown, by Application
11.2.1.4.3 Russia: Europe Bioreactors Market Breakdown, by Technology
11.2.1.4.4 Russia: Europe Bioreactors Market Breakdown, by End User

11.2.1.5 Italy: Europe Bioreactors Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.5.1 Italy: Europe Bioreactors Market Breakdown, by Scale
11.2.1.5.2 Italy: Europe Bioreactors Market Breakdown, by Application
11.2.1.5.3 Italy: Europe Bioreactors Market Breakdown, by Technology
11.2.1.5.4 Italy: Europe Bioreactors Market Breakdown, by End User

11.2.1.6 Rest of Europe: Europe Bioreactors Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.6.1 Rest of Europe: Europe Bioreactors Market Breakdown, by Scale
11.2.1.6.2 Rest of Europe: Europe Bioreactors Market Breakdown, by Application
11.2.1.6.3 Rest of Europe: Europe Bioreactors Market Breakdown, by Technology
11.2.1.6.4 Rest of Europe: Europe Bioreactors Market Breakdown, by End User

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 Applikon Biotechnology BV

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 bbi-biotech GmbH

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 Cellexus International Ltd

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 General Electric Co

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 Merck KGaA

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 Pall Corp

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 PBS Biotech Inc

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 Sartorius AG

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 Solaris Biotechnology SRL

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

14.10 Thermo Fisher Scientific Inc

14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

Europe Bioreactors Market